Mathias Oelke - Nov 22, 2022 Form 4 Insider Report for NexImmune, Inc. (NEXI)

Role
Chief Science Officer
Signature
/s/ John Rudy, Attorney-in-fact
Stock symbol
NEXI
Transactions as of
Nov 22, 2022
Transactions value $
$0
Form type
4
Date filed
11/25/2022, 04:04 PM
Previous filing
Apr 7, 2022
Next filing
Apr 6, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEXI Common Stock Award $0 +126K +1591.57% $0.00 134K Nov 22, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest 100% on the 18-month anniversary of the grant date, subject to Mr. Oelke's continued service through the applicable vesting date.
F2 Excludes 223,634 shares of common stock underlying options that are currently exercisable.